Acquisition of Medications Used in Skin Conditions under AQ2023/490
About This Opportunity
TranslatedThis tender pertains to the acquisition of medications specifically intended for the treatment of skin conditions, as outlined in the AQ2023/490 framework. The procurement aims to ensure the availability of essential pharmaceuticals that address various dermatological issues, thereby enhancing healthcare services in the relevant sector. Key requirements for bidders may include compliance with regulatory standards for pharmaceutical products, proven experience in supplying similar medications, and the ability to meet delivery timelines. The tender is open to qualified suppliers who can demonstrate their capacity to provide high-quality medications that meet the specified therapeutic needs. Interested parties should carefully review the tender documents for detailed specifications, submission guidelines, and evaluation criteria. This procurement is critical for maintaining effective treatment options for patients suffering from skin ailments, and it underscores the commitment to improving public health outcomes. The location for the delivery of these medications will be specified in the tender documents, and potential bidders are encouraged to prepare their proposals accordingly. Overall, this tender represents an important opportunity for suppliers in the pharmaceutical sector to contribute to the healthcare system by providing necessary treatments for skin conditions.
This is a supplies contract in the health and medical services, trade and industry and information and communication technology sectors, with a focus on Pharmaceuticals. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 2,044.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: PortugueseThe tender titled "Aquisição de Medicamentos usados em afeções cutâneas ao abrigo do AQ2023/490" is issued in Portugal, focusing on the procurement of pharmaceuticals intended for the treatment of skin conditions. This initiative falls under the broader framework of public health procurement, aimed at ensuring the availability of essential medications to address dermatological ailments within the healthcare system.
The contracting authority, while not explicitly stated, typically includes public health institutions or relevant government agencies responsible for managing healthcare supplies and services in Portugal. The procurement process is designed to attract qualified suppliers capable of providing a range of dermatological medications that meet stringent quality standards and regulatory compliance.
Typical requirements for this type of tender may include the submission of detailed product specifications, proof of compliance with national and EU pharmaceutical regulations, and evidence of the supplier's capacity to deliver within specified timelines. Bidders may also be required to demonstrate previous experience in supplying similar products to public health entities, alongside providing competitive pricing structures.
As this tender is part of a public contract initiative, it underscores the importance of transparency and fairness in the procurement process. Suppliers interested in participating should prepare to provide comprehensive documentation and adhere to the established submission guidelines.
This procurement opportunity not only aims to enhance the availability of necessary medications but also supports the overarching goal of improving public health outcomes across Portugal.
Data provenance
This notice is sourced from base_gov_pt and was originally published on February 16, 2026. Last refreshed 6 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Unidade Local de Saúde de São José, EPE
Unidade Local de Saúde de São José, EPE has issued 808 procurement notices on BidsFactory, including 15 currently open and 588 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Information & Communication Technology. All notices are published for Portugal. Notices are distributed via base_gov_pt and TED - Tenders Electronic Daily (EU). Most recent publication: June 18, 2026.
Frequently asked questions about this tender
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is Up to €2,044. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to OVERPHARMA,LDA.. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Unidade Local de Saúde de São José, EPE in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.